REFERENCES
- Arimoto K-I, Burkart C, Yan M, Ran D, Weng S, Zhang D-E. 2014. Plakophilin-2 promotes tumor development by enhancing ligand-dependent and -independent epidermal growth factor receptor dimerization and activation. Mol. Cell. Biol. 34:3843–3854. http://dx.doi.org/10.1128/MCB.00758-14.
- Yarden Y, Schlessinger J. 1987. Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. Biochemistry 26:1434–1442. http://dx.doi.org/10.1021/bi00379a034.
- Red Brewer M, Choi SH, Alvarado D, Moravcevic K, Pozzi A, Lemmon MA, Carpenter G. 2009. The juxtamembrane region of the EGF receptor functions as an activation domain. Mol. Cell 34:641–651. http://dx.doi.org/10.1016/j.molcel.2009.04.034.
- Endres NF, Das R, Smith AW, Arkhipov A, Kovacs E, Huang Y, Pelton JG, Shan Y, Shaw DE, Wemmer DE, Groves JT, Kuriyan J. 2013. Conformational coupling across the plasma membrane in activation of the EGF receptor. Cell 152:543–556. http://dx.doi.org/10.1016/j.cell.2012.12.032.
- Arkhipov A, Shan Y, Das R, Endres NF, Eastwood MP, Wemmer DE, Kuriyan J, Shaw DE. 2013. Architecture and membrane interactions of the EGF receptor. Cell 152:557–569. http://dx.doi.org/10.1016/j.cell.2012.12.030.
- Maa M-C, Leu T-H, McCarley DJ, Schatzman RC, Parsons SJ. 1995. Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers. Proc. Natl. Acad. Sci. U. S. A. 92:6981–6985. http://dx.doi.org/10.1073/pnas.92.15.6981.
- Lei H, Kazlauskas A. 2009. Growth factors outside of the platelet-derived growth factor (PDGF) family employ reactive oxygen species/Src family kinases to activate PDGF receptor alpha and thereby promote proliferation and survival of cells. J. Biol. Chem. 284:6329–6336. http://dx.doi.org/10.1074/jbc.M808426200.
- Baroni SS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, Fraticelli P, Sambo P, Funaro A, Kazlauskas A, Avvedimento EV, Gabrielli A. 2006. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N. Engl. J. Med. 354:2667–2676. http://dx.doi.org/10.1056/NEJMoa052955.
- Petti L, Nilson L, DiMaio D. 1991. Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein. EMBO J. 10:845–855.
- Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO, Lindeman N, Gale CM, Zhao X, Christensen J, Kosaka T, Holmes AJ, Rogers AM, Cappuzzo F, Mok T, Lee C, Johnson BE, Cantley LC, Janne PA. 2007. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 316:1039–1043. http://dx.doi.org/10.1126/science.1141478.